Healthcare: Air Liquide Builds New Specialty Ingredients Production Facility in the U.S. for the Cosmetic & Pharmaceutical Ma...
14 October 2016 - 2:52AM
Business Wire
Regulatory News:
Air Liquide (Paris:AI) announces that its subsidiaries
Seppic, healthcare specialty ingredients manufacturer, and Schülke,
hygiene specialist, broke ground on a green-field state of the art
production facility in Sandston, Henrico County - Virginia, United
States. Expected to start operations in the first half of
2018, the planned investment is over $60 million1 and
will create approximately 50 new jobs in the community.
This new production facility will manufacture ingredients
for the cutting-edge cosmetic and pharmaceutical global
markets. The market for personal care specialty ingredients is
worth more than $10 billion globally, of which the U.S.
represents 25%.
With this facility, the two companies will strengthen their
proximity to American customers. The facility is located in the
Northeast of the U.S., where the majority of the companies’
customers are. It will be run by a joint venture between
Seppic and Schülke, named Polykon Manufacturing. Their
resulting synergies will enable to create additional
value in their field of expertise while addressing the growing
need for innovations in these markets.
François Jackow, member of the Air Liquide group’s
Executive Committee, supervising the Healthcare activities, said:
“ Seppic and Schülke have a long presence in the United
States serving leading health and beauty care customers. This first
manufacturing unit for the two companies in the U.S. will extend
their innovative potential and enlarge their industrial footprint
and proximity with customers within North America, while
strengthening their manufacturing capabilities globally. With this
investment, Air Liquide pursues the development of its Hygiene
and Specialty Ingredients activities, thus strengthening the
Group’s Healthcare business in this region. ”
Air Liquide
Healthcaresupplies medical gases, home healthcare
services, hygiene products, medical equipment and specialty
ingredients. In 2015, it served over 7,500 hospitals and 1.3
million patients at home throughout the world. The Group’s
Healthcare business reached €2,800 million in revenues in 2015,
with the support of its 13,500 employees.
Seppic in briefSubsidiary of
the Air Liquide group within the Healthcare activity, Seppic
designs and supplies a wide range of specialty ingredients for
health and beauty care. Present in over 100 countries through its
affiliates and network of distributors, Seppic employs 630 people
around the world, including 100 employees dedicated to innovation.
www.seppic.com
Schülke in briefSubsidiary
of the Air Liquide group within the Healthcare activity and expert
in hospital disinfection, Schülke designs and supplies since more
than 125 years a wide range of disinfectants and antiseptics mainly
for medical environment to actively contribute to patient safety.
Present in 80 countries through its affiliates and network of
distributors, Schülke employs over 900 people around the world,
including 70 researchers. www.schuelke.com
The world leader in gases, technologies and services for
Industry and Health, Air Liquide is present in 80 countries with
approximately 68,000 employees and serves more than 3 million
customers and patients*. Oxygen, nitrogen and hydrogen are
essential small molecules for life, matter and energy. They embody
Air Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Air Liquide’s ambition is to lead its industry, deliver
long-term performance and contribute to sustainability. The
company’s customer-centric transformation strategy aims at
profitable growth over the long term. It relies on operational
excellence, selective investments, open innovation and a network
organization implemented by the Group worldwide. Through the
commitment and inventiveness of its people, Air Liquide leverages
energy and environment transition, changes in healthcare and
digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenues amounted to €16.4 billion in 2015, and
its solutions that protect life and the environment represented
more than 40% of sales. On 23 May 2016, Air Liquide completed its
acquisition of Airgas, which had revenues amounting to $5.3 billion
(around €4.8 billion) for the fiscal year ending 31 March 2016.
Air Liquide is listed on the Paris Euronext stock exchange
(compartment A) and belongs to the CAC 40 and Dow Jones Euro Stoxx
50 indexes.
* Following the acquisition of Airgas on 23 May 2016
1 A 2015 investment decision
www.airliquide.comFollow us on Twitter
@airliquidegroup
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161013006168/en/
Air LiquideCorporate CommunicationsCaroline
Philips, +33 (0)1 40 62 50 84Aurélie Wayser-Langevin, +33 (0)1 40
62 56 19Caroline Brugier, +33 (0)1 40 62 50 59orInvestor
RelationsParis+33 (0)1 40 62 50 87Radnor+1 (0)610 263
8277orAir Liquide Healthcare CommunicationsCoralie Gazzeri,
+33 (0)1 49 69 45 40
C3 AI (NYSE:AI)
Historical Stock Chart
From Jun 2024 to Jul 2024
C3 AI (NYSE:AI)
Historical Stock Chart
From Jul 2023 to Jul 2024